Fab & Doog. thanks for the update on PODRAS application. I didn't think it was approved but I missed when they granted it fast track. that could also explain a lot as to the complexity of the agreement. IPCI would not want to sign off on anything until they know their property is patent protected. while its currently patent pending, that is not legally the same as protected under patent. they especially need to ensure that since any partner will be manufacturing the pill and could steal the technology by reverse engineering. the reason, I bringing this all up is thinking about the ultimate timing of signing a deal. we all know this latest stock offering only gave them enough money to get through November. if they file by end of August, the 74 day letter should come by mid November. assuming its a positive indicator in that notice, it would be proper timing to get the most out of any agreement. AND it would be just in time in order to avoid any further dilution. I agree its going to be a multi point agreement with milestone payments. the company will get the largest upfront payment if it can show the partner does not have to do a phase 3. and the application is accepted. (I know, they were already told they dont need to do a phase 3) that had a condition ! the condition is they dont have to do a phase 3 as long as they can show BE. while the company feels what they are submitting does show BE only one person's idea of if they feel they met BE counts and that is the FDA. so once they get a positive 74 day letter, and thats mid November time frame is when I think we will see the deal coming. just my guess.
News 
Market Data 
Discover 
